Cervical cancer screening in Europe. What next? (Q40739431)

23 September 2017

title

Cervical cancer screening in Europe. What next? (English)

1 reference

23 September 2017

3

1 reference

23 September 2017

1

Franceschi S

1 reference

23 September 2017

Herrero R

2

1 reference

23 September 2017

publication date

1 November 2000

1 reference

European Journal of Cancer

23 September 2017

published in

1 reference

23 September 2017

volume

36

1 reference

23 September 2017

issue

17

1 reference

23 September 2017

page(s)

2272-2275

1 reference

The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

Genital warts and cervical neoplasia: an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

Cervical cancer screening in England

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

Causes of cervical cancer in the Philippines: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

Cervical cancer screening in France

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

HPV testing in primary screening of older women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

International trends in incidence of cervical cancer: II. Squamous-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900340-3

7 January 2021

10.1016/S0959-8049(00)00340-3

Identifiers

DOI

1 reference

23 September 2017

1 reference